Searchable abstracts of presentations at key conferences in endocrinology

ea0056gp156 | Obesity | ECE2018

Pharmacological stimulation of p53 with low-dose doxorubicin ameliorates diet-induced nonalcoholic steatosis and steatohepatitis

Rellan Maria Jesus Gonzalez , Couto Begona Porteiro , Fondevila Marcos Fernandez , Buque Xabier , Fernandez Uxia , Mora Alfonso , Beiroa Daniel , Lopez Miguel , Sabioc Guadalupe , Dieguez Carlos , Aspichueta Patricia , Nogueiras Ruben

Introduction: p53 is a transcription factor involved in many biological functions such as stress, ageing, and metabolism. Although there is a large body of evidence showing that p53 promotes fatty acid catabolism while it inhibits anabolism through the regulation of gene expression, the possible contribution of p53 to the pathogenesis of nonalcoholic fatty liver disease (NAFLD) remains to be elucidated. Also, the anthracycline doxorubicin is an important chemotherapeutic agent...

ea0056p592 | Obesity | ECE2018

Activation of p53 with low doses doxorubicin reduce the acumulation of lipids in two in vitro models of liver steatosis

Fernandez Fondevila Marcos , Porteiro Coto Begona , Buque Xabier , Jesus Gonzalez Rellan Maria , Fernandez Paz Uxia , Mora Alfonso , Beiroa Daniel , Senra Ana , Gallego Rosalia , Lopez Miguel , Sabio Guadalupe , Dieguez Carlos , Aspichueta Patricia , Nogueiras Pozo Ruben

Introduction: p53 is transcription factor widely known because of its antitumoral actions. New evidences suggest that p53 also play a key role in the regulation of metabolic homeostasis and specifically in the lipid metabolism.Objective: We hypothesize that the chemical activation of p53 with low doses of doxorubicin could ameliorate the lipid metabolism in in vitro models of liver steatosis.Methods: We treated with low co...